SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-120394
Filing Date
2022-11-18
Accepted
2022-11-18 17:21:06
Documents
4
Period of Report
2023-01-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2230798-1_pre14a.htm PRE 14A 2191479
2 GRAPHIC sg_forvisllp-bw.jpg GRAPHIC 13909
3 GRAPHIC tm2230798d1-px_page014c.jpg GRAPHIC 1424152
4 GRAPHIC tm2230798d1-px_page024c.jpg GRAPHIC 1557725
  Complete submission text file 0001104659-22-120394.txt   6315244
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31918 | Film No.: 221402882
SIC: 2836 Biological Products, (No Diagnostic Substances)